Skip to main content

Table 1 Characteristics of subjects

From: Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis

 

MPO-ANCA associated vasculitis

Controls (n = 40)

Active-vasculitis (n = 30)

Inactive-vasculitis (n = 30)

Age (years)

71.4 ± 14.2

69.7 ± 13.2

69.3 ± 12.0

Gender (male:female)

17: 13

17: 13

21: 19

Birmingham vasculitis activity score

20.7 ± 5.2*, **

0 ± 0

 

Clinical symptoms

 Fever

21 (70%)*

0 (0%)

 

 Weight loss

10 (33%)*

0 (0%)

 

 Arthralgia

22 (73%)*

0 (0%)

 

 Episcleritis or uvitis

2 (7%)

0 (0%)

 

 Sinusitis

1 (3%)

0 (0%)

 

 Hearing loss

3 (10%)

0 (0%)

 

 Alveolar hemorrhage

5 (17%)

0 (0%)

 

 Interstitial lung disease

15 (50%)

13 (43%)

 

 Arrhythmia

3 (10%)

0 (0%)

 

 Pericarditis

2 (7%)

0 (0%)

 

 Heart failure

9 (30%)*

0 (0%)

 

 Rapidly progressive glomerulonephritis

25 (83%)*

0 (0%)

 

 Peripheral nerve damage

1 (3%)

0 (0%)

 

Laboratory data

 ANCA titer (U/mL)

255.7 ± 178.8*, **

14.2 ± 30.4

 

 White blood cell (/mm3)

9483 ± 3380*, **

8923 ± 3234**

5763 ± 1482

 Hemoglobin conc. (g/dL)

9.1 ± 2.0*, **

11.7 ± 1.8

12.1 ± 2.0

 Platelet count (104/mm3)

27.2 ± 12.0*, **

21.2 ± 5.4

20.2 ± 6.0

 Serum albumin (g/dL)

3.05 ± 0.60*, **

3.74 ± 0.37**

4.10 ± 0.34

 Serum creatinine (mg/dL)

4.55 ± 3.33*, **

3.26 ± 3.96

1.76 ± 1.48

 Serum C-reactive protein (mg/dL)

7.92 ± 6.87*, **

0.18 ± 0.16

0.09 ± 0.12

 Serum 20S-proteasome (mg/dL)

3414.6 ± 2738.9*, **

366.4 ± 128.4

234.9 ± 90.1

Doses of prednisolone (mg daily)

0 ± 0*

5.00 ± 1.97

 
  1. *P < 0.0167 vs. Inactive-vasculitis; **P < 0.0167 vs. Controls